Cargando…

EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer

Detalles Bibliográficos
Autores principales:	Zheng, Xiaofeng, Carstens, Julienne L., Kim, Jiha, Scheible, Matthew, Kaye, Judith, Sugimoto, Hikaru, Wu, Chia-Chin, LeBleu, Valerie S., Kalluri, Raghu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849281/ https://www.ncbi.nlm.nih.gov/pubmed/26560028 http://dx.doi.org/10.1038/nature16064

Ejemplares similares

Dual reporter genetic mouse models of pancreatic cancer identify an epithelial‐to‐mesenchymal transition‐independent metastasis program
por: Chen, Yang, et al.
Publicado: (2018)

4078 Identification of distinct fibroblast populations with unique roles in pancreatic cancer progression and tumor immunity
por: Darpolor, Josephine Kebbeh, et al.
Publicado: (2020)

A peek into cancer-associated fibroblasts: origins, functions and translational impact
por: LeBleu, Valerie S., et al.
Publicado: (2018)

Podoplanin(+) tumor lymphatics are rate limiting for breast cancer metastasis
por: Chen, Yang, et al.
Publicado: (2018)

Epithelial to Mesenchymal Transition induces cell cycle arrest and parenchymal damage in renal fibrosis
por: Lovisa, Sara, et al.
Publicado: (2015)

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
por: Carstens, Julienne L., et al.
Publicado: (2017)

Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer
por: Kamerkar, Sushrut, et al.
Publicado: (2017)

Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2021)

Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer
por: McAndrews, Kathleen M, et al.
Publicado: (2021)

Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses
por: Hensel, Janine, et al.
Publicado: (2020)

Activin–like kinase–3 activity is important for kidney regeneration and reversal of fibrosis
por: Sugimoto, Hikaru, et al.
Publicado: (2012)

EMT is not required for lung metastasis but contributes to chemoresistance
por: Fischer, Kari R., et al.
Publicado: (2015)

Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity
por: Kugeratski, Fernanda G., et al.
Publicado: (2023)

Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer
por: Carstens, Julienne L., et al.
Publicado: (2021)

DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer
por: Zhang, Jinyu, et al.
Publicado: (2020)

PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis
por: LeBleu, Valerie S., et al.
Publicado: (2014)

Tumor microenvironment controls the rate of cancer progression and metastasis
por: Kalluri, Raghu
Publicado: (2010)

NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells
por: Zhou, Ya, et al.
Publicado: (2017)

Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2021)

Transition to resistance: An unexpected role of the EMT in cancer chemoresistance
por: Wang, Jing, et al.
Publicado: (2016)

MiRNA-mediated EMT and CSCs in cancer chemoresistance
por: Dong, Bing, et al.
Publicado: (2021)

The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells
por: Lee, Kyung-Jun, et al.
Publicado: (2023)

Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation
por: Wang, Huiru, et al.
Publicado: (2015)

Depletion of S100A4(+) stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors
por: Jiao, Jingjing, et al.
Publicado: (2018)

EMT and tumor metastasis
por: Heerboth, Sarah, et al.
Publicado: (2015)

Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer
por: Zhou, Xunian, et al.
Publicado: (2021)

Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta
por: Chen, Yang, et al.
Publicado: (2021)

Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT
por: Yang, Yan, et al.
Publicado: (2019)

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression
por: Laklai, Hanane, et al.
Publicado: (2016)

Role of EMT in Metastasis and Therapy Resistance
por: Smith, Bethany N., et al.
Publicado: (2016)

EMT and MET: necessary or permissive for metastasis?
por: Jolly, Mohit Kumar, et al.
Publicado: (2017)

Type XVIII collagen is essential for survival during acute liver injury in mice
por: Duncan, Michael B., et al.
Publicado: (2013)

Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
por: Chiou, Shin-Heng, et al.
Publicado: (2018)

GBA Regulates EMT/MET and Chemoresistance in Squamous Cell Carcinoma Cells by Modulating the Cellular Glycosphingolipid Profile
por: Clark, Laura E., et al.
Publicado: (2023)

Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
por: Recouvreux, Maria Victoria, et al.
Publicado: (2020)

Disconnect between EMT and metastasis in pancreas cancer
por: Whittle, Martin C., et al.
Publicado: (2015)

Context-dependent EMT programs in cancer metastasis
por: Aiello, Nicole M., et al.
Publicado: (2019)

Role of ACTN4 in Tumorigenesis, Metastasis, and EMT
por: Tentler, Dmitri, et al.
Publicado: (2019)

Deciphering the mechanism of Peptostreptococcus anaerobius-induced chemoresistance in colorectal cancer: the important roles of MDSC recruitment and EMT activation
por: Gu, Jinhua, et al.
Publicado: (2023)

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cdgu7h6r1hedc3785ivj5ob096